GENE ONLINE|News &
Opinion
Blog

2017-12-22|

December 22, 1955: German-American Biochemist Thomas Christian Südhof was Born

by GeneOnline
Share To

Thomas Christian Südhof (December 22, 1955 – present) is a German-American biochemist known for his study of synaptic transmission. Under the supervision of Michael Stuart Brown and Joseph L. Goldstein during his postdoctoral research fellowship, Südhof worked to describe the role of the LDL receptor in cholesterol metabolism, which contributed to the development of hypolipidemic agents. After finishing postdoctoral training, Südhof started his independent research career in neuroscience since 1986 and open the field of molecular neuroscience for synaptic transmission. Südhof shared the 2013 Nobel Prize in Physiology or Medicine with Randy Schekman and James Rothman for their phenomenal research.

Reference
https://en.wikipedia.org/wiki/Thomas_C._S%C3%BCdhof

Image Source
https://en.wikipedia.org/wiki/Thomas_C._S%C3%BCdhof

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Pioneering Vaccine Offers Hope for Affordable Cholesterol Management
2023-12-20
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top